Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra (RBT)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by Harriet Shezi Children's Clinic.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Harriet Shezi Children's Clinic
ClinicalTrials.gov Identifier:
NCT01259219
First received: December 13, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):